ranolazine

Generic: ranolazine

Labeler: micro labs limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ranolazine
Generic Name ranolazine
Labeler micro labs limited
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

ranolazine 500 mg/1

Manufacturer
Micro Labs Limited

Identifiers & Regulatory

Product NDC 42571-324
Product ID 42571-324_d172a3c8-ae0a-9ccb-e053-2a95a90a069e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211745
Listing Expiration 2026-12-31
Marketing Start 2020-06-01

Pharmacologic Class

Established (EPC)
anti-anginal [epc]
Mechanism of Action
cytochrome p450 3a inhibitors [moa] p-glycoprotein inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] organic cation transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42571324
Hyphenated Format 42571-324

Supplemental Identifiers

RxCUI
616749 728231
UPC
0342571324605 0342571325602
UNII
A6IEZ5M406
NUI
N0000175427 N0000190114 N0000185503 N0000182137 N0000187061

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ranolazine (source: ndc)
Generic Name ranolazine (source: ndc)
Application Number ANDA211745 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-05)
  • 100 BLISTER PACK in 1 CARTON (42571-324-11) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (42571-324-32)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-60)
  • 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-64)
source: ndc

Packages (4)

42571-324-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-05) 42571-324-11 100 BLISTER PACK in 1 CARTON (42571-324-11) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (42571-324-32) 42571-324-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-60) 42571-324-64 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-64)

Ingredients (1)

ranolazine (500 mg/1)

Linked Drug Pages (1)

Ranolazine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d172a3c8-ae0a-9ccb-e053-2a95a90a069e", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "upc": ["0342571324605", "0342571325602"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["f6facddc-c020-436e-8e68-bf9a4223e7cf"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-05)", "package_ndc": "42571-324-05", "marketing_start_date": "20200601"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (42571-324-11)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (42571-324-32)", "package_ndc": "42571-324-11", "marketing_start_date": "20200601"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-60)", "package_ndc": "42571-324-60", "marketing_start_date": "20200601"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-324-64)", "package_ndc": "42571-324-64", "marketing_start_date": "20200601"}], "brand_name": "Ranolazine", "product_id": "42571-324_d172a3c8-ae0a-9ccb-e053-2a95a90a069e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "42571-324", "generic_name": "Ranolazine", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA211745", "marketing_category": "ANDA", "marketing_start_date": "20200601", "listing_expiration_date": "20261231"}